Zobrazeno 1 - 10
of 10
pro vyhledávání: '"I. V. Trigolosova"'
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 45, Iss 4, Pp 326-332 (2017)
Rationale: Prevalence of neoplasms in patients with acromegaly and the effects of various risk factors on their development have been insufficiently studied.Aim: To assess the prevalence of thyroid, gastric and colon neoplasms in patients with newly
Externí odkaz:
https://doaj.org/article/56acff97f2d8442789b5e172afa94b51
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 44, Iss 5, Pp 568-579 (2017)
Acromegaly is a rare disease with increased growth hormone secretion most often caused by pituitary adenoma. Not adequately treated acromegaly may lead to early death related to increased rates of acute cardiovascular events, sleep apnea, metabolic d
Externí odkaz:
https://doaj.org/article/c33295488b2342b5aac4cc32f4146a32
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 31-35 (2016)
Background: Somatostatin analogues therapy is an important part of the acromegalic patients’ treatment. Aim: Assessment of treatment efficiency for patients with acromegaly using different doses of somatostatin analogues. Materials and methods: The
Externí odkaz:
https://doaj.org/article/4eb5ed034ad846fda336988b717bf345
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 0, Iss 32, Pp 89-96 (2016)
There are many endocrine diseases accompanied by development of secondary diabetes mellitus (sDM). The features of the development and course of sDM in acromegaly, Cushing’s syndrome, and growth hormone (GH) deficiency are of particular interest as
Externí odkaz:
https://doaj.org/article/d8c6d2465b7b435d8e736fa3f41fe70e
Publikováno v:
Ожирение и метаболизм, Vol 10, Iss 4, Pp 21-25 (2013)
Aim of the study was to investigate the features of glucose metabolism in patients with acromegaly depending on treatment. Materials and methods: 63 patients with acromegaly: 29 patients with newly diagnosed acromegaly, 25 patients receiving somatost
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0f190954189f5b2a3dbbe194e7e9a2a
https://www.omet-endojournals.ru/jour/article/view/6386
https://www.omet-endojournals.ru/jour/article/view/6386
Publikováno v:
Эндокринная хирургия, Vol 7, Iss 1, Pp 49-53 (2013)
Aim of this study was to investigate efficiency and safety of OctreotidLong FS in patients with acromegaly. Materials and methods. 41 patients with acromegaly (8 – de novo and 33 patients after different somato statin analogs treatment) was treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3484185d61cfafa3385f5e230cf06073
https://surg-endojournals.ru/serg/article/viewFile/6371/4217
https://surg-endojournals.ru/serg/article/viewFile/6371/4217
Publikováno v:
Ожирение и метаболизм, Vol 7, Iss 1, Pp 41-45 (2010)
The aim of this study was to investigate the effect of acute hyperinsulinemia to fasting leptin level (fL) secretion and leptin secretion during intravenouse glucose tolerance test (IVGTT). Methods. 32 T2DM women without antidiabetic drugs were studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a1680ce149c58b8d3dcbf78cf1364e
https://doi.org/10.14341/2071-8713-5277
https://doi.org/10.14341/2071-8713-5277
Publikováno v:
Ожирение и метаболизм, Vol 6, Iss 4, Pp 23-27 (2009)
We have performed an estimation of metabolic disorders in 70 persons with various early glucose metabolism abnormalities (IFG and IGT). Oral glucose tolerance test (ОGTT) and intravenous glucose tolerance test (IVGTT) were done in all subjects. HbA1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b2ab17831c6dbf221c5680a31b5c22
https://doi.org/10.14341/2071-8713-4874
https://doi.org/10.14341/2071-8713-4874
Publikováno v:
Problems of Endocrinology. 58:9-11
To estimate the prevalence of diabetes mellitus (DM) among the patients with acromegaly residing in the Moscow region (MR). A total of 93 patients aged from 48.0 to 64.5 (mean 57.5) years presenting with acromegaly from 7.5 to 20.25 (mean 13.0) years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b69f3f25c5d70af9bc349dc180ca722
https://doi.org/10.14341/probl20125839-11
https://doi.org/10.14341/probl20125839-11
Publikováno v:
Эндокринная хирургия, Vol 7, Iss 1, Pp 49-53 (2013)
Aim of this study was to investigate efficiency and safety of OctreotidLong FS in patients with acromegaly. Materials and methods. 41 patients with acromegaly (8 – de novo and 33 patients after different somato statin analogs treatment) was treated
Externí odkaz:
https://doaj.org/article/4d2364f209f1428abf7f1eebbed22f38